Location: Home
  • search
  • go
  • Relate News
  • 12/13/2022111 Begins Online Sales of Pfizer's Covid Drug Paxlovid
  • 12/13/2022Pfizer to Improve Supply of COVID Drug Paxlovid in China
  • 12/2/2022China's Challenge in the Drug Services Field (C&EN)
  • 11/30/2022WuXi STA Launches Another Parenteral Formulation Manufacturing Line at...
  • 11/23/2022WuXi AppTec Begins Construction of Wuxi STA's East China R&D Facility
  • 10/30/2022Ascletis Pharma Ends Down After Pfizer Supply Deal Sent Stock Soaring
  • 10/26/2022WuXi Bio Launches 48,000L Commercial Drug Substance Manufacturing Faci...
  • 10/20/2022IQVIA Forecasts Chinese CMDO Market to Grow 20% CAGR Before 2025
  • 10/19/2022Fitch: US Biomanufacturing Plan Poses Minor Risks to Chinese Pharma CD...
  • 10/8/2022U.S. Adds 31 Additional Chinese Cos to Unverified List, But Removing A...
  • 9/28/2022Parexel Opens Clinical Trial Supplies and Logistics Depot in Suzhou
  • 9/27/2022WuXi STA Opens First High Potency Oral Drug Product Manufacturing Faci...
  • 9/27/2022CDMO Asymchem Plans CNY 5B Manufacturing Facility in Taixing
  • 9/12/2022WuXi STA Opens a New Sterile Lipid Nanoparticle Formulation Facility t...
  • 9/12/2022CFIUS Derails Asymchem's Acquisition of Snapdragon
  • 8/30/2022RoosterBio and MBL Beijing Biotech Partner to Accelerate Advanced Ther...
  • 8/19/2022Pfizer Signs China Partnership to Make Paxlovid Covid Pills Locally
  • 8/17/2022WuXi STA Breaks Ground for 2nd Drug Manufacturing Facility in the U.S.
  • 7/21/2022WuXi Biologics Plans to Build a Comprehensive CRDMO Center in Singapor...
  • 7/19/2022WuXi STA Opens a New Large Scale Continuous Manufacturing Plant
  • 7/19/2022WuXi AppTec Plans to Build a New Site in Singapore with Planned S$2B I...
  • 7/14/2022CStone Considers Sale Amid Mounting Challenges: Bloomberg
  • 7/7/2022Pharmaron Acquires Commercial API Manufacturing Facility in the U.S.
  • 7/1/2022Eurofins DiscoverX Establishes A New China Biotechnology Office
  • 6/29/2022WuXi STA Opens Another High-Potency API Plant In Changzhou
  • 6/23/2022GlobalData: Borrena (lorlatinib) Approval Further Strengthens Pfizer P...
  • 6/7/2022CanSino and Pfizer Terminate vaccine deal
  • 6/6/2022WuXi Biologics Launches First Commercial Drug Product Facility for Pre...
  • 6/3/2022NeoGenomics's Suzhou Pharma Services Lab Gets CAP Certification
  • 5/24/2022Vir and WuXi Bio Terminate COVID Antibody Agreement
  • Page:5/27 Total number of articles:793: [First][<<] [3] [4] [5] [6] [7] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group